Please ensure Javascript is enabled for purposes of website accessibility

Why Clover Health Stock Surged Today

By Joe Tenebruso – Aug 12, 2021 at 4:15PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The upstart is gaining share in the massive Medicare Advantage market.

What happened

Shares of Clover Health (CLOV 0.82%) climbed 10.8% on Thursday, following the release of the healthcare insurance provider's second-quarter results.  

So what

Clover Health's revenue soared 140% year over year to $412.5 million. Total lives under Clover Management at the end of the second quarter jumped 126% to approximately 129,000, split roughly evenly among Medicare Advantage memberships and Direct Contracting.

"Clover took another step in its journey to improve every life with the launch of Direct Contracting this past quarter," CEO Vivek Garipalli said in a press release. "This milestone more than doubled our revenue and nearly doubled lives under Clover Assistant management."

A person is holding an upwardly sloping bar chart.

Investors applauded Clover Health's Q2 growth metrics. Image source: Getty Images.

The company's Clover Assistant program shares its data platform with healthcare providers. By providing convenient access to health records and real-time clinical data, Clover Health can help medical professionals provide more personalized care to their patients. Additionally, participating providers are more quickly reimbursed for their services. Unsurprisingly, the program has proved popular among clinicians.

"The Clover Assistant continues to be a key differentiator which underpins our unique model," chief technology officer Andrew Toy said. "The Clover Assistant has approximately 95,000 lives under management and is on pace to manage over $1 billion of annualized revenue."

Still, Clover Health is not yet profitable. The company generated a net loss of $317.6 million in the second quarter.

Now what 

Management expects Clover Health to earn full-year revenue of $1.4 billion to $1.5 billion in 2021, driven by growth of 17% to 21% in its Medicare Advantage membership base.

"We have ambitious goals to maintain an aggressive growth trajectory while pursuing our mission to improve every life by making great healthcare available and affordable to all American seniors regardless of health, wealth, or economic status," Garipalli said.

Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Clover Health Investments Stock Quote
Clover Health Investments
CLOV
$1.23 (0.82%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
351%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.